The present invention relates to a compound of the Formula (I)):
or pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same, a method for treating or preventing viral infections, inflammation, dry eye, central nervous disorders, cardiovascular diseases, cancer, obesity, diabetes, muscular dystrophy, and hair loss.
Process for producing epoxyalcohols of high optical purity
申请人:ARCO Chemical Technology, L.P.
公开号:EP0454463A2
公开(公告)日:1991-10-30
A process for enriching or improving the optical purity of an asymmetric epoxidation reaction mixture is provided wherein one chiral epoxy alcohol enantiomer, preferably the one present in minor amounts, is effectively separated from the other chiral epoxy alcohol enantiomer by converting the former to an epoxy ester by stereoselective transesterification using a carboxylic acid derivative such as an enol ester and a lipase enzyme and then recovering the desired chiral epoxy alcohol enantiomer or reacting it in situ to form a chiral epoxy alcohol derivative.